242 related articles for article (PubMed ID: 30325692)
1. Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects.
Demant M; Bagger JI; Suppli MP; Lund A; Gyldenløve M; Hansen KB; Hare KJ; Christensen M; Sonne DP; Holst JJ; Vilsbøll T; Knop FK
Metab Syndr Relat Disord; 2018 Dec; 16(10):530-536. PubMed ID: 30325692
[TBL] [Abstract][Full Text] [Related]
2. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
[TBL] [Abstract][Full Text] [Related]
3. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes.
Toft-Nielsen MB; Madsbad S; Holst JJ
J Clin Endocrinol Metab; 2001 Aug; 86(8):3853-60. PubMed ID: 11502823
[TBL] [Abstract][Full Text] [Related]
4. Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.
Gignac T; Trépanier G; Paquet V; Ferland S; Carreau AM
Can J Diabetes; 2023 Oct; 47(7):603-610. PubMed ID: 37352972
[TBL] [Abstract][Full Text] [Related]
5. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
6. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
Maruszczak K; Radzikowski K; Schütz S; Mangge H; Bergsten P; Forslund A; Manell H; Pixner T; Ahlström H; Kullberg J; Mörwald K; Weghuber D
Front Endocrinol (Lausanne); 2022; 13():1004128. PubMed ID: 36133310
[TBL] [Abstract][Full Text] [Related]
7. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
[TBL] [Abstract][Full Text] [Related]
8. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
Gastaldelli A; Baldi S; Pettiti M; Toschi E; Camastra S; Natali A; Landau BR; Ferrannini E
Diabetes; 2000 Aug; 49(8):1367-73. PubMed ID: 10923639
[TBL] [Abstract][Full Text] [Related]
9. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
[TBL] [Abstract][Full Text] [Related]
10. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
Davidson MB; Schriger DL; Peters AL; Lorber B
JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
[TBL] [Abstract][Full Text] [Related]
11. Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
Acta Diabetol; 2014 Aug; 51(4):567-75. PubMed ID: 24442427
[TBL] [Abstract][Full Text] [Related]
12. Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients.
Lee M; Kim M; Park JS; Lee S; You J; Ahn CW; Kim KR; Kang S
Korean J Intern Med; 2019 Sep; 34(5):1068-1077. PubMed ID: 28882024
[TBL] [Abstract][Full Text] [Related]
13. Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population.
Kumaravel B; Bachmann MO; Murray N; Dhatariya K; Fenech M; John WG; Scarpello TJ; Sampson MJ;
Diabetes Res Clin Pract; 2012 May; 96(2):211-6. PubMed ID: 22257419
[TBL] [Abstract][Full Text] [Related]
14. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.
Ko GT; Chan JC; Tsang LW; Cockram CS
Diabetes Care; 2000 Dec; 23(12):1770-3. PubMed ID: 11128350
[TBL] [Abstract][Full Text] [Related]
15. The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.
Ortiz R; Kluwe B; Odei JB; Echouffo Tcheugui JB; Sims M; Kalyani RR; Bertoni AG; Golden SH; Joseph JJ
Psychoneuroendocrinology; 2019 May; 103():25-32. PubMed ID: 30623794
[TBL] [Abstract][Full Text] [Related]
16. Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.
Sjöstrand M; Iqbal N; Lu J; Hirshberg B
Diabetes Res Clin Pract; 2014 Aug; 105(2):185-91. PubMed ID: 24947443
[TBL] [Abstract][Full Text] [Related]
17. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
[TBL] [Abstract][Full Text] [Related]
18. Relationships between hemoglobin A 1c and spot glucose measurements in Nigerians with type 2 diabetes mellitus.
Edo AE; Akhuemokhan K
Niger J Clin Pract; 2012; 15(1):23-6. PubMed ID: 22437083
[TBL] [Abstract][Full Text] [Related]
19. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
Jakubowicz D; Wainstein J; Ahren B; Landau Z; Bar-Dayan Y; Froy O
Diabetes Care; 2015 Oct; 38(10):1820-6. PubMed ID: 26220945
[TBL] [Abstract][Full Text] [Related]
20. The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes.
Hædersdal S; Lund A; Maagensen H; Nielsen-Hannerup E; Gasbjerg LS; Rosenkilde MM; Forman JL; van Hall G; Holst JJ; Knop FK; Vilsbøll T
Eur J Endocrinol; 2022 Jan; 186(2):207-221. PubMed ID: 34863038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
